• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TAM 受体 Axl 和 Mer 对肝脏生理和损伤的差异化调节。

Differential regulation of hepatic physiology and injury by the TAM receptors Axl and Mer.

机构信息

Molecular Neurobiology Laboratory, The Salk Institute, La Jolla, CA, USA.

Instituto de Investigaciones Biomédicas Alberto Sols (CSIC-UAM), Madrid, Spain.

出版信息

Life Sci Alliance. 2020 Jun 22;3(8). doi: 10.26508/lsa.202000694. Print 2020 Aug.

DOI:10.26508/lsa.202000694
PMID:32571802
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7335405/
Abstract

Genome-wide association studies have implicated the TAM receptor tyrosine kinase (RTK) Mer in liver disease, yet our understanding of the role that Mer and its related RTKs Tyro3 and Axl play in liver homeostasis and the response to acute injury is limited. We find that Mer and Axl are most prominently expressed in hepatic Kupffer and endothelial cells and that as mice lacking these RTKs age, they develop profound liver disease characterized by apoptotic cell accumulation and immune activation. We further find that Mer is critical to the phagocytosis of apoptotic hepatocytes generated in settings of acute hepatic injury, and that Mer and Axl act in concert to inhibit cytokine production in these settings. In contrast, we find that Axl is uniquely important in mitigating liver damage during acetaminophen intoxication. Although Mer and Axl are protective in acute injury models, we find that Axl exacerbates fibrosis in a model of chronic injury. These divergent effects have important implications for the design and implementation of TAM-directed therapeutics that might target these RTKs in the liver.

摘要

全基因组关联研究表明 TAM 受体酪氨酸激酶 (RTK) Mer 与肝脏疾病有关,但我们对 Mer 及其相关 RTKs Tyro3 和 Axl 在肝脏稳态和对急性损伤的反应中的作用的了解有限。我们发现 Mer 和 Axl 在肝库普弗细胞和内皮细胞中表达最为显著,而当缺乏这些 RTKs 的小鼠衰老时,它们会发展为特征为凋亡细胞积累和免疫激活的严重肝脏疾病。我们进一步发现,Mer 对于清除急性肝损伤时产生的凋亡肝细胞的吞噬作用至关重要,并且 Mer 和 Axl 在这些情况下协同作用以抑制细胞因子的产生。相比之下,我们发现 Axl 在对乙酰氨基酚中毒期间减轻肝损伤方面具有独特的重要性。尽管 Mer 和 Axl 在急性损伤模型中具有保护作用,但我们发现 Axl 在慢性损伤模型中加剧了纤维化。这些不同的影响对于设计和实施 TAM 靶向治疗具有重要意义,这些治疗可能会在肝脏中靶向这些 RTKs。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca06/7335405/83835be1a539/LSA-2020-00694_Fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca06/7335405/5c10660a34ba/LSA-2020-00694_Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca06/7335405/4315e4dbfda2/LSA-2020-00694_Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca06/7335405/a1b52b8ed054/LSA-2020-00694_FigS1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca06/7335405/8c6cc8c0d490/LSA-2020-00694_Fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca06/7335405/83835be1a539/LSA-2020-00694_Fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca06/7335405/5c10660a34ba/LSA-2020-00694_Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca06/7335405/4315e4dbfda2/LSA-2020-00694_Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca06/7335405/a1b52b8ed054/LSA-2020-00694_FigS1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca06/7335405/8c6cc8c0d490/LSA-2020-00694_Fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca06/7335405/83835be1a539/LSA-2020-00694_Fig6.jpg

相似文献

1
Differential regulation of hepatic physiology and injury by the TAM receptors Axl and Mer.TAM 受体 Axl 和 Mer 对肝脏生理和损伤的差异化调节。
Life Sci Alliance. 2020 Jun 22;3(8). doi: 10.26508/lsa.202000694. Print 2020 Aug.
2
A Functional Role of GAS6/TAM in Nonalcoholic Steatohepatitis Progression Implicates AXL as Therapeutic Target.GAS6/TAM 在非酒精性脂肪性肝炎进展中的功能作用提示 AXL 可作为治疗靶点。
Cell Mol Gastroenterol Hepatol. 2020;9(3):349-368. doi: 10.1016/j.jcmgh.2019.10.010. Epub 2019 Nov 2.
3
Differential TAM receptor-ligand-phospholipid interactions delimit differential TAM bioactivities.不同的TAM受体-配体-磷脂相互作用界定了不同的TAM生物活性。
Elife. 2014 Sep 29;3:e03385. doi: 10.7554/eLife.03385.
4
TAM receptors and the regulation of erythropoiesis in mice.TAM受体与小鼠红细胞生成的调节
Haematologica. 2009 Mar;94(3):326-34. doi: 10.3324/haematol.13635. Epub 2009 Feb 11.
5
The TAM-family receptor Mer mediates production of HGF through the RhoA-dependent pathway in response to apoptotic cells.TAM 家族受体 Mer 通过 RhoA 依赖的途径介导 HGF 的产生,以响应凋亡细胞。
Mol Biol Cell. 2012 Aug;23(16):3254-65. doi: 10.1091/mbc.E12-01-0029. Epub 2012 Jun 27.
6
Receptor tyrosine kinases, TYRO3, AXL, and MER, demonstrate distinct patterns and complex regulation of ligand-induced activation.受体酪氨酸激酶TYRO3、AXL和MER表现出不同的模式以及配体诱导激活的复杂调控。
J Biol Chem. 2014 Sep 12;289(37):25750-63. doi: 10.1074/jbc.M114.569020. Epub 2014 Jul 29.
7
Targeting Axl and Mer kinases in cancer.针对癌症中的 Axl 和 Mer 激酶。
Mol Cancer Ther. 2011 Oct;10(10):1763-73. doi: 10.1158/1535-7163.MCT-11-0116. Epub 2011 Sep 20.
8
Paradoxical role of the proto-oncogene Axl and Mer receptor tyrosine kinases in colon cancer.原癌基因 Axl 和 Mer 受体酪氨酸激酶在结肠癌中的矛盾作用。
Proc Natl Acad Sci U S A. 2013 Aug 6;110(32):13091-6. doi: 10.1073/pnas.1302507110. Epub 2013 Jul 22.
9
High incidence of distal vaginal atresia in mice lacking Tyro3 RTK subfamily.缺乏Tyro3受体酪氨酸激酶亚家族的小鼠中阴道远端闭锁的高发生率。
Mol Reprod Dev. 2008 Dec;75(12):1775-82. doi: 10.1002/mrd.20917.
10
TAM receptor tyrosine kinase function and the immunopathology of liver disease.TAM受体酪氨酸激酶功能与肝脏疾病的免疫病理学
Am J Physiol Gastrointest Liver Physiol. 2016 Jun 1;310(11):G899-905. doi: 10.1152/ajpgi.00382.2015. Epub 2016 Feb 11.

引用本文的文献

1
Dual roles and therapeutic targeting of tumor-associated macrophages in tumor microenvironments.肿瘤微环境中肿瘤相关巨噬细胞的双重作用及治疗靶点
Signal Transduct Target Ther. 2025 Aug 25;10(1):268. doi: 10.1038/s41392-025-02325-5.
2
Inhibition of Axl attenuates acute kidney injury by alleviating inflammation via SOCS3 downregulation in tubular epithelial cells.抑制Axl可通过下调肾小管上皮细胞中的SOCS3减轻炎症,从而减轻急性肾损伤。
BMC Nephrol. 2025 Jul 1;26(1):325. doi: 10.1186/s12882-025-04222-z.
3
Kupffer cell expression of macrophage receptor with collagenous structure modulates macrophage gene induction and limits acute liver injury.

本文引用的文献

1
Macrophage MerTK Promotes Liver Fibrosis in Nonalcoholic Steatohepatitis.巨噬细胞 MerTK 促进非酒精性脂肪性肝炎中的肝纤维化。
Cell Metab. 2020 Feb 4;31(2):406-421.e7. doi: 10.1016/j.cmet.2019.11.013. Epub 2019 Dec 12.
2
Expression of AXL receptor tyrosine kinase relates to monocyte dysfunction and severity of cirrhosis.AXL 受体酪氨酸激酶的表达与单核细胞功能障碍及肝硬化严重程度相关。
Life Sci Alliance. 2019 Dec 10;3(1). doi: 10.26508/lsa.201900465. Print 2020 Jan.
3
A Functional Role of GAS6/TAM in Nonalcoholic Steatohepatitis Progression Implicates AXL as Therapeutic Target.
具有胶原结构的巨噬细胞受体在库普弗细胞中的表达可调节巨噬细胞基因诱导并限制急性肝损伤。
Toxicol Sci. 2025 Jun 1;205(2):417-427. doi: 10.1093/toxsci/kfaf037.
4
The Liver X Receptor Promotes Immune Homeostasis via Controlled Activation of the Innate Immune System in the Liver.肝脏X受体通过对肝脏固有免疫系统的可控激活促进免疫稳态。
Biomolecules. 2024 Dec 28;15(1):25. doi: 10.3390/biom15010025.
5
RNase T2 deficiency promotes TLR13-dependent replenishment of tissue-protective Kupffer cells.核糖核酸酶T2缺乏促进Toll样受体13依赖性的组织保护性库普弗细胞补充。
J Exp Med. 2025 Mar 3;222(3). doi: 10.1084/jem.20230647. Epub 2025 Jan 24.
6
Extracellular vesicles containing GAS6 protect the liver from ischemia-reperfusion injury by enhancing macrophage efferocytosis via MerTK-ERK-COX2 signaling.含有生长停滞特异性蛋白6(GAS6)的细胞外囊泡通过MerTK-ERK-COX2信号通路增强巨噬细胞的胞葬作用,从而保护肝脏免受缺血再灌注损伤。
Cell Death Discov. 2024 Sep 10;10(1):401. doi: 10.1038/s41420-024-02169-y.
7
Dynamic changes in immune cell populations by AXL kinase targeting diminish liver inflammation and fibrosis in experimental MASH.靶向 AXL 激酶可改变免疫细胞群的动态变化,从而减轻实验性 MASH 中的肝脏炎症和纤维化。
Front Immunol. 2024 May 16;15:1400553. doi: 10.3389/fimmu.2024.1400553. eCollection 2024.
8
In the Eyes of the Beholder-New Knockout Mouse and Re-Evaluation of Phagocytosis versus Anti-Inflammatory Functions of MERTK.在旁观者的眼中——新型敲除小鼠及其对 MERTK 吞噬作用与抗炎功能的重新评价。
Int J Mol Sci. 2024 May 13;25(10):5299. doi: 10.3390/ijms25105299.
9
Administration of Gas6 attenuates lung fibrosis via inhibition of the epithelial-mesenchymal transition and fibroblast activation.Gas6 给药通过抑制上皮-间充质转化和纤维母细胞激活来减轻肺纤维化。
Cell Biol Toxicol. 2024 Apr 5;40(1):20. doi: 10.1007/s10565-024-09858-5.
10
Phosphatidylserine externalization as immune checkpoint in cancer.磷脂酰丝氨酸外化作为癌症中的免疫检查点。
Pflugers Arch. 2024 Dec;476(12):1789-1802. doi: 10.1007/s00424-024-02948-7. Epub 2024 Apr 4.
GAS6/TAM 在非酒精性脂肪性肝炎进展中的功能作用提示 AXL 可作为治疗靶点。
Cell Mol Gastroenterol Hepatol. 2020;9(3):349-368. doi: 10.1016/j.jcmgh.2019.10.010. Epub 2019 Nov 2.
4
Gas6/TAM System: A Key Modulator of the Interplay between Inflammation and Fibrosis.Gas6/TAM 系统:炎症与纤维化相互作用的关键调节因子。
Int J Mol Sci. 2019 Oct 12;20(20):5070. doi: 10.3390/ijms20205070.
5
How macrophages deal with death.巨噬细胞如何应对死亡。
Nat Rev Immunol. 2019 Sep;19(9):539-549. doi: 10.1038/s41577-019-0167-y.
6
Acetaminophen Hepatotoxicity.对乙酰氨基酚肝毒性。
Semin Liver Dis. 2019 May;39(2):221-234. doi: 10.1055/s-0039-1679919. Epub 2019 Mar 8.
7
The Myeloid-Epithelial-Reproductive Tyrosine Kinase (MERTK) rs4374383 Polymorphism Predicts Progression of Liver Fibrosis in Hepatitis C Virus-Infected Patients: A Longitudinal Study.髓样上皮生殖酪氨酸激酶(MERTK)rs4374383多态性预测丙型肝炎病毒感染患者肝纤维化进展:一项纵向研究
J Clin Med. 2018 Nov 23;7(12):473. doi: 10.3390/jcm7120473.
8
Acetaminophen (APAP or N-Acetyl-p-Aminophenol) and Acute Liver Failure.对乙酰氨基酚(APAP 或 N-乙酰基对氨基酚)与急性肝衰竭。
Clin Liver Dis. 2018 May;22(2):325-346. doi: 10.1016/j.cld.2018.01.007. Epub 2018 Feb 9.
9
Phosphatidylserine Is the Signal for TAM Receptors and Their Ligands.磷脂酰丝氨酸是TAM受体及其配体的信号分子。
Trends Biochem Sci. 2017 Sep;42(9):738-748. doi: 10.1016/j.tibs.2017.06.004. Epub 2017 Jul 19.
10
Soluble Axl is an accurate biomarker of cirrhosis and hepatocellular carcinoma development: results from a large scale multicenter analysis.可溶性Axl是肝硬化和肝细胞癌发展的准确生物标志物:一项大规模多中心分析的结果
Oncotarget. 2017 Jul 11;8(28):46234-46248. doi: 10.18632/oncotarget.17598.